Company / Capital Returned to Shareholders per Share
Cullinan Therapeutics, Inc. Capital Returned to Shareholders per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.22
FY2021
5-year range
$0.22 / $0.33
FY2020-FY2021
Trend
-33.3%
vs FY2020
Sector context
#38 of 51
Health Care
What the data says
Cullinan Therapeutics, Inc.'s capital returned to shareholders per share of $0.22 is lower than 75% of companies in the Health Care sector (FY2021).
Based on SEC 10-K filings.
0.22 in FY2021.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 51This company $0.22 Sector average $2.74
▼
-91.9% below sector average
Key checks
Key Insights
- In FY2021, capital returned to shareholders per share decreased 33.3% year-over-year.
- Ranks #38 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.22 | -33.3% |
| FY2020 | $0.33 | - |
As of FY2021 · SEC 10-K · Updated Jul 2, 2026